Pharma company investors call for clinical trials transparency
In an unprecedented move, a group of 85 asset managers and pension funds is teaming with a U.K. non-profit campaign (AllTrials campaign) to pressure pharmaceutical companies to disclose clinical trial data (i.e. get clinical trials registered and results reported). The investors represent more than €3.5 trillion in assets.
Read more in the Financial Times and Wall Street Journal.
Leave a Reply